Optimal Timing of Inner Cell Mass Isolation Increases the Efficiency of Human Embryonic Stem Cell Derivation and Allows Generation of Sibling Cell Lines  by Chen, Alice E. et al.
Cell Stem Cell
Brief ReportOptimal Timing of Inner Cell Mass Isolation Increases
the Efficiency of Human Embryonic Stem Cell
Derivation and Allows Generation of Sibling Cell Lines
Alice E. Chen,4,8 Dieter Egli,4,8 Kathy Niakan,4 Jie Deng,7 Hidenori Akutsu,5 Mariko Yamaki,4 Chad Cowan,1,2,6
Claire Fitz-Gerald,4 Kun Zhang,7 Douglas A. Melton,2,3,4,* and Kevin Eggan1,2,4,*
1The Stowers Medical Institute
2Harvard Stem Cell Institute
3Howard Hughes Medical Institute
4Department of Stem Cell and Regenerative Biology
Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA
5National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya, Tokyo 157-8535, Japan
6Massachussetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA
7Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA
8These authors contributed equally to this work
*Correspondence: dmelton@harvard.edu (D.A.M.), eggan@mcb.harvard.edu (K.E.)
DOI 10.1016/j.stem.2008.12.001The capacity of human embryonic stem
cells (hESCs) to self-renew indefinitely in
culturewhile retaining their ability to differ-
entiate into all cell typessuggests that they
have enormous potential both in medical
applications and as a research tool (Reu-
binoff et al., 2000; Thomson et al., 1998).
Despite their immortal nature, there is
a need for derivation of new hESC lines
to meet emerging requirements for their
use in cell replacement therapies, disease
modeling, andbasic research. Theneed to
optimize the use of donatedor experimen-
tally generated embryos motivated our
attempts to improve methods for the
derivation of hESC lines, which have led
to practical recommendations and the
generation of sibling hESC lines.
Following the derivation of 17 hESC lines
(Cowan et al., 2004), we derived an addi-
tional 12 lines using the same method
and found that the efficiency of these deri-
vations varied greatly from experiment to
experiment (see Table S1 available online).
To better understand the variables that
affect derivation efficiency, we explored
methods for ICM isolation and systemati-
cally investigated the relationship between
preimplantation biology and the timing of
ESC derivation. We found that in vitro-
cultured human preimplantation embryos
undergo major changes in morphology as
well as expression of OCT4 and CDX2
from days 5–9 postfertilization. We
observed a peak of derivation efficiency
using day 6 preimplantation embryos, cor-
responding to restriction of OCT4 to the
ICM and CDX2 to the trophectoderm (TE).
These comparative studies have led to
the derivation of 45 new hESC lines from
140 blastocysts, of which 22 cell lines are
derived from sibling embryos. Global
gene expression analysis of hESC lines
reveals that lines derived on different
days do not significantly differ from one
another in transcriptional profile, but lines
derived from different genetic back-
grounds do significantly differ, suggest-
ing that genetic background, rather than
the timing or method of derivation, is a
contributing factor in the variability
observed among hESC lines.
The most widely usedmethod for hESC
derivation involves either chemical or
enzymatic removal of the zona pellucida,
followed by isolation of the inner cell
mass (ICM) of the blastocyst by immuno-
surgery (Reubinoff et al., 2000; Thomson
et al., 1998). In immunosurgery, cells of
the TE are destroyed by brief exposure to
antibodies directed against human cells in
tandem with complement activity (Solter
and Knowles, 1975). However, only high-
quality embryos with an intact TE can be
subjected to this procedure, as only the
structural integrity of the blastocyst pre-
vents the ICM from also being destroyed.
We reasoned that isolation of the ICM by
laser-mediated ablation of the zona pellu-
cida and TE might reduce exposure of the
ICM to potentially cytotoxic compounds.
The 584 frozen human embryos used in
this study were donated for research
following informed consent under proto-
cols reviewed and approved by both the
Committee on the Use of Human Subjects
(IRB) and the Embryonic Stem Cell
Research Oversight Committee (ESCRO)
at Harvard University. Human zygotes
and cleavage-stage embryos were
thawed and cultured to the blastocyst
stage (Figure S1A). ICM isolation was
carried out by exposing TE cells to cell-
lethal laser pulses from a XYClone laser
(see also Turetsky et al., 2008) and subse-
quent removal of dead TE cells either by
using piezo drill-assisted micromanipula-
tion or by repeated aspiration into
a 50–75 mm glass capillary pipette (Fig-
ures S1B and S1C). The isolated ICM
(FigureS1D)was thenplatedontog-irradi-
ated mouse embryonic fibroblasts (MEFs)
in hESC-conditioned derivation media.
Isolated ICMs attached to the MEF
feeder cell layer within 24 hr and 4–13
days later gave rise to an ESC outgrowth
(Figures S1E–S1G) composed of cells
with typical hESC morphology (Figure
S1H) that could be expanded into cell lines
(Figures S1I and S1J). HESC lines isolated
by laser surgery had a normal karyotype
(Figure S1K) and expressed marker anti-
gens found in pluripotent hESCs, including
OCT4, SOX2, NANOG, TRA1-81, TRA1-
60, and SSEA-4 (Figures S2A–S2F). Upon
differentiation in vitro, via embryoid body
formation (Figures S2G–S2I), and in vivo,
via teratoma formation (Figures S2J–
S2O), endoderm, mesoderm, and ecto-
derm lineages were readily observed,
demonstrating that these cell lines are
bona fide hESCs (Thomson et al., 1998;
The InternationalStemCell Initiative, 2007).
Next, we investigated the conse-
quences of the presence or absence of
TE cells in the derivation culture. We
compared the efficiency of deriving
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Day of ICM Isolation
Number of
Blastocysts
Used for
Derivation
Number of
Attachment Sites
(Percent of
Blastocysts)
Number of ICM
Outgrowths
Number of Cell
Lines
Percent
Derivation
Efficiency
5 19 6 (31) 1 1 5
6 27 22 (81) 15 14 52a
7 27 22 (81) 9 9 33
8 19 17 (90) 5 5 26
9 11 10 (91) 4 4 36
No isolation 10 10 (100) 1 1 10
Unknownb 27 ND ND 11 40
Derivation efficiency is expressed as percent according to the number of cell lines obtained per total number of blastocysts used for derivation. Results
summarize derivations using both laser surgery and immunosurgery. A more detailed presentation of the results is given in Table S2.
a p = 0.00002, comparison between day 6 and day 5; p = 0.008, comparison between day 6 and no isolation (assuming binomial distribution).
b HUES 18–28 (see also Table S1).hESCs following plating of intact blasto-
cysts without ICM isolation with the effi-
ciency following ICM isolation on days
5–9 of development (with the day of
insemination representing day 0). While
derivation from plating intact blastocysts
has previously been reported (Baharvand
et al., 2004; Bongso et al., 1994; Genba-
cev et al., 2005; Heins et al., 2004), we
found that the efficiency was low (10%
of blastocysts used) and required close
outgrowth monitoring in order to isolate
the ICM before it was lost to rapid differ-
entiation (Table 1 and Figure S3).
To investigate the effects of the timingof
ICM isolation on hESC derivation, we
systematically tested the derivation effi-
ciencies with ICMs isolated from early
blastocysts (day 5) through late blasto-
cysts (day9).During thisprolongedculture
period, we observed a number ofmorpho-
logical changes. Between days 5 and 6,
ICM cell number increased while cell size
decreased, and the TE of high-quality
embryos expanded (Figure S4A). Both
the ICM and TE of blastocysts continued
to grow through day 6 of in vitro culture,
but by day 7, the TE frequently collapsed
and deteriorated, even in high-quality
embryos (Figure S4B). In contrast to the
TE, cells in the interior of the embryo
continued to grow. For embryo culture
beyond day 6, a shift from global medium
to hESC-conditioned medium improved
development, particularly in poor-quality
embryos with a small or indiscernible
ICM. In extremely compromised embryos,
we switched to conditioned media as
early as day 5. Surprisingly, poor-quality
embryos without an ICM on day 5 or 6
often developed a distinct ICM after 1–2
days of additional culture (Figures S4C
and S4D) in hESC-conditioned media.
Extended culture of these embryos occa-
sionally resulted in anatypicalmorphology
inwhich the interior cells of theblastocysts
expanded to form a solid sphere (Figures
S4E and S4F), but no disadvantage was
observed in subsequent hESC derivation
(Table 1 and Table S2).
We found that hESC llines could be
derived from embryos at days 5–9 after
fertilization, with ICM isolation on day 6 re-
sulting in the most efficient derivation of
hESCs (Table 1). HESCs have previously
been isolated on various days of develop-
ment (Hovatta et al., 2003; Mitalipova
et al., 2003; Stojkovic et al., 2004; Strom
et al., 2007) and even from blastomeres
and morula-stage embryos (Chung et al.,
2008; Klimanskaya et al., 2006; Strel-
chenkoet al., 2004). The lownumber of cell
lines generated, however, did not allow a
conclusion to be drawn regarding the effi-
ciency of derivation. Isolation of the ICMon
day6 resulted ina10-fold increaseover the
derivation efficiency on day 5 (52%, n = 27
versus 5%, n = 19, respectively; p =
0.00002). This is also 5-fold higher than
derivation without isolation of the ICM
(52%, n = 27 versus 10%, n = 10, respec-
tively; p = 0.008). Derivation efficiency
correlated with the total number of ICM
attachment sites to the feeder layer after
ICM plating. The number of attachment
sites and resulting cell lines was low on
day 5 but increased onday 6 and remained
high on days 7–9. Derivation efficiency on
days 7–9 was slightly lower but not signifi-
cantly different from derivation on day 6
(p > 0.01). Poor-quality embryos benefited
greatly from extended culture in hESC-
conditioned media, as only 1–2 days of
additional culture promoted ICM growth
and allowed hESC derivation (Figures
S4C–S4F, Table S2). This approach al-
lowed for derivation of ESCs fromembryos
that would have otherwise been unlikely to
give rise to hESC lines (e.g., grade 2CC
embryos, HUES 33, 43, 57; grade 3CC
embryos, HUES 32, 54, 59, 64). In sum-
mary, by combining extended embryo
culture in hESC-conditioned media with
laser-assisted isolation of the ICM on day
6 of preimplantation development, a deri-
vation efficiency of 50% can be routinely
achieved.
Using these methods, we succeeded in
deriving a total of 22 sibling cell lines from
seven donor couples (Table S3). To verify
their identical maternal origin and demon-
strate their karyotypic individuality, we
sequenced the hypervariable regions of
the mitochondrial genome and a com-
bination of nuclear short tandem repeats
(STRs) and compared them to unrelated
hESC lines. While their mitochondrial
genome was identical, their nuclear
genome was different but highly related,
sharing more than 50% of STR alleles
(Table S4 and Figures S5 and S6).
Next, we explored whether differences
in efficiency of hESC derivation corre-
late with a change in localization and
expression of the respective ICM and TE
markers, OCT4 and CDX2. It has been
shown in mouse preimplantation embryos
that by the 65–128 cell stage, OCT4
becomes restricted to the ICM, and CDX2
to the TE, at approximately 3.5 days post-
fertilization in in vitro-cultured blastocysts
(Dietrich and Hiiragi, 2007; Ralston and
Rossant, 2008). We therefore asked
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Brief ReportFigure 1. OCT4 and CDX2 Expression during Human Preimplantation Development and Gene Expression Analysis of hESC Lines
(A–C) Representative human preimplantation embryos on day 5 (A), day 6 (B), and day 8 (C) stained for the TE marker, CDX2, and ICM marker, OCT4. Total cell
numbers typically found for each day are indicated. Scale bar indicates relative size for comparison.
(D) Cluster analysis of 16 hESC lines derived on different days of development. Sibling cell lines are marked with identical colors.
(E and F) Pairwise comparison of global gene expression profiles between different cell lines. Comparison of 16 cell lines yields 163 15/2 = 120 data points for all
possible pairwise comparisons. The higher the Pearson correlation coefficient (R), the more similar the gene expression profile between two lines. Pairs were
ordered from high to low according to the Pearson correlation coefficient (ranked order). (E) Pairwise comparisons of hESC lines derived on the same versus
different days. (F) Pairwise comparisons of sibling hESC lines versus unrelated lines.whether OCT4 and CDX2 expression and
localization in human preimplantation
embryos could explainwhyderivation after
day 6 of in vitro culture is more efficient.
Embryos used in stem cell derivation
are most commonly staged in terms of
days postfertilization, with the day of
insemination representing day 0. We
observed that the majority of human
embryos at day 5 (approximately 40–75
cells, blastocyst grade 3) had high levels
of OCT4 expression in both the ICM and
TE, while some embryos had begun to
express CDX2 in some, but not all, of the
TE (Figure 1A). By day 6 (approximately
75–145 cells, blastocyst grades 4 and 5),
blastocysts exhibited a clear restriction
of high levels of OCT4 expression to the
ICM and of CDX2 to the TE (Figure 1B).
By day 8, OCT4 expression was confined
to a small number of cells in the presump-
tive ICM (Figure 1C). As most of cells of
the day 8 embryo did not express OCT4
or CDX2, this observation suggests that
a cell type other than ICM or TE prolifer-
ates at this late stage in vitro. While the
identity of these cells is unclear, their
proliferation and survival are minimal
upon ICM explant for hESC derivation.
Together, these observations suggest
that the ICM and TE cells of early day 5
blastocysts may not yet be restricted to
either fate, and therefore isolated ICMcells
only rarely give rise toESCs. The restriction
of OCT4 expression to the ICM and of
CDX2 to the TE on day 6, together with
the increase in ICM cell number, may
explainwhyderivationonday6 ismosteffi-
cient. Once segregation of the ICM and TE
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ciency remains high on days 7–9 (Table 1)
despite a reduction in the number of
OCT4-expressing cells.
Themorphological andmolecular differ-
encesweobserved betweenpreimplanta-
tion embryos at various developmental
time points led us to question whether
hESCs derived from embryos on days 5–
9 differ in their gene expression programs.
It was suggested that pluripotent stem
cells isolated from the epiblast of mouse
peri-implantation embryos are the mouse
equivalent to hESCs. These epiblast
stem cells differ in their gene expression
profile from mouse ESCs isolated from
preimplantation stage embryos and share
similarities to hESCs (Brons et al., 2007;
Tesar et al., 2007).We therefore examined
whether hESC lines derived fromdays 5–9
generate different types of stem cell lines.
We found that hESC lines isolated from
different days of development were iden-
tical in their growth requirements and ex-
pressed the same pluripotency-associ-
ated antigens (Table S2). We further
analyzed the gene expression profile of
16 hESC lines derived on days 5–9 of
development and found that these lines
did not group into separate clusters based
on their day of derivation (Figure 1D). The
distribution of pairwise correlation coeffi-
cients (R) between lines derived from the
same day of development was indistin-
guishable from lines derived from different
days (Student’s t test, p = 0.12, Figure 1E).
In contrast, when all pairwise correlation
coefficients were grouped according
to genetically related versus unrelated
lines, the similarity between sibling lines
was significantly higher than between
unrelated lines (Student’s t test, p = 1.13
108, Figure 1F). These observations
suggest that the gene expression differ-
ences among hESC lines are due to
genetic parentage rather than the day or
method of derivation. Such differences
likely contribute to the variation in differen-
tiation propensity reported between hESC
lines (The International StemCell Initiative,
2007; Osafune et al., 2008).
The 50% derivation efficiency we
achieved using day 6 embryos, laser
surgery, and modified embryo culture
parameters was higher than previously re-
ported from either our or other laborato-
ries (Cowan et al., 2004; Lerou et al.,
2008; Thomson et al., 1998) (Table S5).
The increased efficiency and reliability of
this method has also allowed us to derive
cohorts of stem cell lines that would
not have previously been obtainable,
including 22sibling cell lines. These sibling
cell lines will be a valuable resource for
further investigation of the effects of
genetic background on the growth char-
acteristics, pluripotency, and differentia-
tion potential of hESCs.
Our findings increase the probability of
successful derivation from rare embryos
such as those obtained after preimplanta-
tion genetic diagnosis or somatic cell
nuclear transplantation. A detailed under-
standing of the naturally occurring varia-
tions among hESC lines will also be
important for insight into the genetic regu-
lation of human development as well as
for evaluating pluripotent stem cells
generated by reprogramming.
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